Solexa will present at the UBS Global Life Sciences Conference at 4:30pm Eastern Standard Time on Monday 25 September 2006 at the Grand Hyatt Hotel in New York City
A live webcast of the presentation will be broadcast via the internet.
Those interested in listening to the webcast will find a link to the webcast registration page on Solexa's website.
An archived replay of the presentation will also be available approximately one hour following the live presentation and may be accessed for 14 days.
Solexa is developing and commercialising the Solexa Genome Analysis System, which will be used to perform a range of analyses including whole genome resequencing, gene expression analysis and small RNA analysis.
Solexa expects its first-generation instrument, the 1G Genome Analyzer, to generate over a billion bases of DNA sequence per run and to enable human genome resequencing below $100,000 per sample, making it the first platform to reach this important milestone.
Solexa's longer-term goal is to reduce the cost of human re-sequencing to a few thousand dollars for use in a wide range of applications from basic research through clinical diagnostics.
